Patent No. EP4121512 (titled "Heart Tissue Model") was filed by Imba Institut FR Molekulare Biotechnologie on Mar 19, 2021. The application was issued on Aug 21, 2024.
Heart tissue model generated through directed differentiation of pluripotent stem cells into cardiac cells in a 3D culture system. The model mimics early heart development by forming a continuous cardiomyocyte layer around an inner cavity, with endocardial cells lining the cavity. The model is generated through a combination of natural growth factors and inhibitors, allowing for precise control over cell differentiation and organization. The model exhibits cardiac cell-cell interactions and maintains a functional beating rhythm, making it a valuable tool for studying cardiac development and disease mechanisms.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents